MedTrace Logo

Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes

NCT04665999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2022-04-06

No results posted yet for this study

Summary

This is an observational study. Forty females with type 1 diabetes (age 18-40) using a continuous glucose monitor and an insulin pump will be enrolled for a 3-month data collection. Study participants will include free-cycling females and females following oral contraceptive therapy. All study appointments may be completed virtually.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

Continuous Glucose Monitor

Data collection only

Sponsors & Collaborators

  • DexCom, Inc.

    collaborator INDUSTRY

  • University of Virginia

    lead OTHER

Principal Investigators

  • Chiara Fabris, PhD · University of Virginia Center for Diabetes Technology

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2022-03-10
Completion
2022-03-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04665999 on ClinicalTrials.gov